Stock Picking
Simplified
Stockopedia takes your stock picking to the next level with cutting edge Stock Reports & Screening tools.
Latest Stockopedia Features
Beating earnings expectations tends to be a sure fire way for companies to hit the financial headlines and get a warm reception from shareholders on results day. For momentum investors with an eye for a surprise, keeping track of these City stars has long been…
Latest Ideas from our Contributors
Part 1: Introduction and basic value I like doing sectoral comparisons between companies. I think most of us intuitively understand that, at the most basic level, similar companies should command similar prices in the market - though defining 'similar prices' (what metric? how similar?) is…

Yesterday's announcement that the $5bn Jarden Corporation was making a bid for ICAP Securities Exchange tiddler Sprue Aegis wouldn't have threatened many headlines, but hidden within…

Pre 8 a.m. comments Good morning! My Twitter feed is buzzing this morning with chatter about the Japanese market having dropped 6% overnight. I'm really glad…

While the opinions of brokers often attract legitimate scepticism among investors, there’s little doubt that anyone keeping an eye on our analyst upgrade screen recently would…

Pre 8 a.m. comments I'll comment on Zytronic (LON:ZYT) after 8 a.m., as it's not especially time sensitive. Things that might be time sensitive include a…
Product Development
After many months of work & testing, we are glad to announce that Stockopedia's European Edition is now live! The most requested feature by users on our Suggestion List has long been internationalisation - well, you can now analyse, rank and screen over 8000 shares…

Join us this Thursday May 23rd when we will be doing a free interactive Demo webinar designed to discuss systematic investing techniques & how best to…
AstraZeneca
AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company. AstraZeneca discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation. It… ... view Stock Report »
AstraZeneca is currently qualifying under the criteria for the following 6 screens: James O'Shaugnessy's Cornerstone Va… , Dividend Dogs of the FTSE , Josef Lakonishok Screen , 52 Week High Momentum Screen… , Dividend Dogs (Forecast) of the FTS… , The Screens of Screens


















